HK Stock MarketDetailed Quotes

02235 MICROTECH MED-B

Watchlist
  • 4.000
  • +0.010+0.25%
Market Closed Apr 19 16:08 CST
1.70BMarket Cap-12345P/E (TTM)

MICROTECH MED-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
Turnover
45.86%253.23M
54.29%110.81M
14.66%173.61M
--71.82M
101.13%151.4M
45.15%75.28M
--51.86M
Operating income
45.86%253.23M
54.29%110.81M
14.66%173.61M
71.82M
101.13%151.4M
45.15%75.28M
51.86M
Cost of sales
----
----
----
----
-107.89%-80.52M
-39.43%-38.73M
---27.78M
Operating expenses
-39.08%-127.49M
-32.83%-53.2M
-13.85%-91.67M
-40.05M
-107.89%-80.52M
-39.43%-38.73M
-27.78M
Gross profit
53.45%125.73M
81.32%57.61M
15.59%81.94M
31.77M
93.97%70.88M
51.74%36.54M
24.08M
Selling expenses
-80.03%-210.09M
-76.72%-68.92M
-123.32%-116.7M
---39M
5.09%-52.26M
-103.90%-55.06M
---27M
Administrative expenses
-9.79%-45.6M
-57.54%-22.57M
-0.13%-41.53M
---14.32M
9.35%-41.48M
-36.12%-45.76M
---33.62M
Research and development expenses
-14.75%-70.1M
-30.23%-32.02M
-69.29%-61.09M
---24.59M
56.00%-36.08M
-63.82%-82.01M
---50.06M
Profit from asset sales
----
----
---8.31K
----
----
----
----
Revaluation surplus
---15.62K
----
----
----
----
----
----
-Changes in the fair value of other assets
---15.62K
----
----
----
----
----
----
Impairment and provision
8.72%-4.51M
-388.66%-2.59M
-302.24%-4.94M
---529K
-553.72%-1.23M
55.56%-188K
---423K
-Other impairment is provision
8.72%-4.51M
-388.66%-2.59M
-302.24%-4.94M
---529K
-553.72%-1.23M
55.56%-188K
---423K
Special items of operating profit
-53.19%10.59M
-34.77%972K
87.99%22.61M
--1.49M
-52.88%12.03M
192.92%25.53M
--8.72M
Operating profit
-62.29%-195.31M
-49.23%-68.18M
-150.02%-120.35M
-45.69M
60.20%-48.14M
-54.45%-120.94M
-78.3M
Financing cost
-12.14%75.04M
31.06%49.55M
502,458.72%85.4M
--37.81M
94.48%-17K
0.96%-308K
---311K
Special items of earning before tax
-4,796.74%-4.58M
46.03%-34K
---93.53K
---63K
----
----
----
Earning before tax
-256.30%-124.85M
-134.99%-18.66M
27.23%-35.04M
-7.94M
60.29%-48.15M
-54.23%-121.25M
-78.61M
Tax
-10,755.18%-163.62K
----
---1.51K
----
----
----
----
After-tax profit from continuing operations
-256.75%-125.02M
-134.99%-18.66M
27.23%-35.04M
-7.94M
60.29%-48.15M
-54.23%-121.25M
-78.61M
Earning after tax
-256.75%-125.02M
-134.99%-18.66M
27.23%-35.04M
-7.94M
60.29%-48.15M
-54.23%-121.25M
-78.61M
Minority profit
----
----
----
----
----
---241K
----
Profit attributable to shareholders
-256.75%-125.02M
-134.99%-18.66M
27.23%-35.04M
-7.94M
60.21%-48.15M
-53.93%-121.01M
-78.61M
Basic earnings per share
-262.50%-0.29
-100.00%-0.04
38.46%-0.08
-0.02
66.67%-0.13
-39.29%-0.39
-0.28
Diluted earnings per share
-262.50%-0.29
-100.00%-0.04
38.46%-0.08
-0.02
66.67%-0.13
-39.29%-0.39
-0.28
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
HKAS
HKAS
HKAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Auditor
Tianjian Certified Public Accountants (Special General Partnership)
--
Ernst & Young
--
Ernst & Young
Ernst & Young
Ernst & Young
(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019
Turnover 45.86%253.23M54.29%110.81M14.66%173.61M--71.82M101.13%151.4M45.15%75.28M--51.86M
Operating income 45.86%253.23M54.29%110.81M14.66%173.61M71.82M101.13%151.4M45.15%75.28M51.86M
Cost of sales -----------------107.89%-80.52M-39.43%-38.73M---27.78M
Operating expenses -39.08%-127.49M-32.83%-53.2M-13.85%-91.67M-40.05M-107.89%-80.52M-39.43%-38.73M-27.78M
Gross profit 53.45%125.73M81.32%57.61M15.59%81.94M31.77M93.97%70.88M51.74%36.54M24.08M
Selling expenses -80.03%-210.09M-76.72%-68.92M-123.32%-116.7M---39M5.09%-52.26M-103.90%-55.06M---27M
Administrative expenses -9.79%-45.6M-57.54%-22.57M-0.13%-41.53M---14.32M9.35%-41.48M-36.12%-45.76M---33.62M
Research and development expenses -14.75%-70.1M-30.23%-32.02M-69.29%-61.09M---24.59M56.00%-36.08M-63.82%-82.01M---50.06M
Profit from asset sales -----------8.31K----------------
Revaluation surplus ---15.62K------------------------
-Changes in the fair value of other assets ---15.62K------------------------
Impairment and provision 8.72%-4.51M-388.66%-2.59M-302.24%-4.94M---529K-553.72%-1.23M55.56%-188K---423K
-Other impairment is provision 8.72%-4.51M-388.66%-2.59M-302.24%-4.94M---529K-553.72%-1.23M55.56%-188K---423K
Special items of operating profit -53.19%10.59M-34.77%972K87.99%22.61M--1.49M-52.88%12.03M192.92%25.53M--8.72M
Operating profit -62.29%-195.31M-49.23%-68.18M-150.02%-120.35M-45.69M60.20%-48.14M-54.45%-120.94M-78.3M
Financing cost -12.14%75.04M31.06%49.55M502,458.72%85.4M--37.81M94.48%-17K0.96%-308K---311K
Special items of earning before tax -4,796.74%-4.58M46.03%-34K---93.53K---63K------------
Earning before tax -256.30%-124.85M-134.99%-18.66M27.23%-35.04M-7.94M60.29%-48.15M-54.23%-121.25M-78.61M
Tax -10,755.18%-163.62K-------1.51K----------------
After-tax profit from continuing operations -256.75%-125.02M-134.99%-18.66M27.23%-35.04M-7.94M60.29%-48.15M-54.23%-121.25M-78.61M
Earning after tax -256.75%-125.02M-134.99%-18.66M27.23%-35.04M-7.94M60.29%-48.15M-54.23%-121.25M-78.61M
Minority profit -----------------------241K----
Profit attributable to shareholders -256.75%-125.02M-134.99%-18.66M27.23%-35.04M-7.94M60.21%-48.15M-53.93%-121.01M-78.61M
Basic earnings per share -262.50%-0.29-100.00%-0.0438.46%-0.08-0.0266.67%-0.13-39.29%-0.39-0.28
Diluted earnings per share -262.50%-0.29-100.00%-0.0438.46%-0.08-0.0266.67%-0.13-39.29%-0.39-0.28
Currency Unit CNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)HKASHKASHKAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified OpinionUnqualified OpinionUnqualified Opinion
Auditor Tianjian Certified Public Accountants (Special General Partnership)--Ernst & Young--Ernst & YoungErnst & YoungErnst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg